Esperion Therapeutics
ESPR
ESPR
102 hedge funds and large institutions have $148M invested in Esperion Therapeutics in 2016 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 43 increasing their positions, 28 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less first-time investments, than exits
New positions opened: | Existing positions closed:
45% less capital invested
Capital invested by funds: $267M → $148M (-$119M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
102
Holding in Top 10
–
Calls
$1.25M
Puts
$1.48M
Top Buyers
| 1 | +$2.95M | |
| 2 | +$2.41M | |
| 3 | +$2.29M | |
| 4 |
SAM
Senzar Asset Management
New York
|
+$2.17M |
| 5 |
FMA
FNY Managed Accounts
New York
|
+$1.98M |
Top Sellers
| 1 | -$18.9M | |
| 2 | -$10.7M | |
| 3 | -$2.79M | |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$2.23M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.13M |